Andrew Reardon
CLO & Secretary · 10 filings · Latest: Oct 2, 2026
LIGAND PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LGND | ANDREW THOMAS REARDON | — | May 15, 2025 | Proposed Sale | $104.00 | 1,000 | $104.0K | — | |
LGND | Reardon Andrew | — | Sep 23, 2024 | Proposed Sale | $99.60 | 2,000 | $199.2K | — | |
LGND | Reardon Andrew | — | Aug 28, 2024 | Proposed Sale | $106.39 | 1,500 | $159.6K | — |
← Previous
Page 2 of 2